Cargando…

Vasoactive intestinal peptide in canine portosystemic shunt in the absence of portal hypertension

BACKGROUND: The congenital portosystemic shunt (PSS) is a common vascular anomaly in dogs. Vasoactive intestinal peptide (VIP) is produced in various organs (including the small intestine, large intestine, and pancreas), leading to abdominal vasodilation, increased blood flow, increased pancreatic b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Isaka, Mitsuhiro, Ueno, Hiroshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Faculty of Veterinary Medicine 2021
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057220/ https://www.ncbi.nlm.nih.gov/pubmed/33898282 http://dx.doi.org/10.4314/ovj.v11i1.7

Ejemplares similares

Transjugular Intrahepatic Portosystemic Shunt Versus Surgical Shunting in the Management of Portal Hypertension
por: Huang, Long, et al.
Publicado: (2015)

Transjugular intrahepatic portosystemic stent-shunt in the management of portal hypertension
por: Tripathi, Dhiraj, et al.
Publicado: (2020)

Transjugular Intrahepatic Portosystemic Shunt for the Treatment of Portal Hypertension in Noncirrhotic Patients with Portal Cavernoma
por: Luo, Xuefeng, et al.
Publicado: (2014)

The Transjugular Intrahepatic Portosystemic Shunt in the Treatment of Portal Hypertension: Current Status
por: Pomier-Layrargues, Gilles, et al.
Publicado: (2012)

Modified gun-sight transjugular intrahepatic portosystemic shunt technique
por: Lukies, Matthew, et al.
Publicado: (2022)

Acquired Hepatocerebral Degeneration in the Absence of Portosystemic Shunting
por: Caranci, Giovanni, et al.
Publicado: (2019)

The role of transjugular intrahepatic portosystemic shunt in patients with portal hypertension: Advantages and pitfalls
por: Lee, Hae Lim, et al.
Publicado: (2022)

Transjugular intrahepatic portosystemic shunt for pediatric portal hypertension: A meta-analysis
por: Raissi, Driss, et al.
Publicado: (2023)

Application of transmesenteric vein extrahepatic portosystemic shunt in treatment of symptomatic portal hypertension with cavernous transformation of portal vein
por: Li, Weixiao, et al.
Publicado: (2023)

The Role of Transjugular Intrahepatic Portosystemic Shunt (TIPS) in Treating Portal Hypertension in Patients with Hepatocellular Carcinoma
por: Balducci, Daniele, et al.
Publicado: (2023)

Transjugular intrahepatic portosystemic shunt for the treatment of portal hypertensive biliopathy with cavernous transformation of the portal vein: a case report
por: Zhao, Ming, et al.
Publicado: (2022)

Transjugular intrahepatic portosystemic shunt with radioactive seed strand for main portal vein tumor thrombosis with cirrhotic portal hypertension
por: Yan, Xuan-Hui, et al.
Publicado: (2022)

Aberrant hepatic lipid storage and metabolism in canine portosystemic shunts
por: Van den Bossche, Lindsay, et al.
Publicado: (2017)

Successful Treatment of Small Intestinal Bleeding in a Crohn's Patient with Noncirrhotic Portal Hypertension by Transjugular Portosystemic Shunt Placement and Infliximab Treatment
por: Heimgartner, Benjamin, et al.
Publicado: (2016)

Asymptomatic presentation of a congenital malformation of the portal vein with portosystemic shunt
por: Musa, Juna, et al.
Publicado: (2020)

Effects of transjugular intrahepatic portosystemic shunt treatment of patients with liver cirrhosis and portal hypertension: Case series
Publicado: (2021)

Efficacy and safety of laparoscopic splenectomy for hypersplenism secondary to portal hypertension after transjugular intrahepatic portosystemic shunt
por: Li, Yingying, et al.
Publicado: (2021)

Effects of transjugular intrahepatic portosystemic shunt treatment of patients with liver cirrhosis and portal hypertension: Case series
por: Zheng, Dan, et al.
Publicado: (2021)

Clinical outcomes of transjugular intrahepatic portosystemic shunt for portal hypertension: Korean multicenter real-practice data
por: Kim, Hyung Ki, et al.
Publicado: (2014)

Safety and efficacy of transfemoral intrahepatic portosystemic shunt for portal hypertension: A single-center retrospective study
por: Zhang, Yu, et al.
Publicado: (2019)

Anticoagulation after transjugular intrahepatic portosystemic shunt for portal hypertension: A systematic review and meta analysis
por: Jiao, Pan, et al.
Publicado: (2022)

Pressure-Dependent Elevation of Vasoactive Intestinal Peptide Level in Chicken Choroid
por: Privalov, Evgeny, et al.
Publicado: (2023)

Repeated specific canine pancreatic lipase measurements do not identify multiple acquired portosystemic shunts in dogs after extrahepatic portosystemic shunt attenuation
por: Serrano, Gonçalo, et al.
Publicado: (2023)

Effects of transjugular intrahepatic portosystemic shunt treatment of patients with liver cirrhosis and portal hypertension: Case series: Erratum
Publicado: (2021)

Splenophrenic portosystemic shunt in dogs with and without portal hypertension: can acquired and congenital porto-caval connections coexist?
por: Ricciardi, M.
Publicado: (2016)

Can a laparoscopic surgery be an alternative to transjugular intrahepatic portosystemic shunts (TIPS) for the treatment of portal hypertensive bleeding?
por: Huang, Bin, et al.
Publicado: (2023)

Advanced portal venous access techniques for transjugular intrahepatic portosystemic shunt placement
por: Partovi, Sasan, et al.
Publicado: (2021)

Transjugular intrahepatic portosystemic shunt via left hepatic – left portal veins
por: Maleux, Geert
Publicado: (2019)

Acquired Portosystemic Shunts in Cirrhosis and Portal Vein Thrombosis: A Case Report
por: Durgham, Anthony, et al.
Publicado: (2022)

Regenerative and fibrotic pathways in canine hepatic portosystemic shunt and portal vein hypoplasia, new models for clinical hepatocyte growth factor treatment
por: Spee, Bart, et al.
Publicado: (2005)

Portal hypertension exacerbates intrahepatic portosystemic venous shunt and further induces refractory hepatic encephalopathy: A case report
por: Chang, Ying-Hao, et al.
Publicado: (2021)

Refractory portal hypertension complications successfully managed by parallel transjugular intrahepatic portosystemic shunt (TIPS): a case report
por: Weeratunga, Senali, et al.
Publicado: (2022)

A novel nomogram predicting overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in portal hypertension patients
por: Liao, Yong, et al.
Publicado: (2023)

Transsplenic portal vein reconstruction–transjugular intrahepatic portosystemic shunt in a patient with portal and splenic vein thrombosis
por: Salsamendi, Jason T., et al.
Publicado: (2016)

Transjugular Intrahepatic Portosystemic Shunt for Maintenance of Portal Venous Patency in Liver Transplant Candidates
por: Gaba, Ron Charles, et al.
Publicado: (2013)

Multiple acquired portosystemic shunts secondary to primary hypoplasia of the portal vein in a cat
por: SUGIMOTO, Satoko, et al.
Publicado: (2018)

Transjugular Intrahepatic Portosystemic Shunt as the Treatment for Refractory Hepatic Hydrothorax with Portal Vein Thrombosis
por: Zhang, Lin-Hao, et al.
Publicado: (2017)

Role of vasoactive intestinal peptide in osteoarthritis
por: Jiang, Wei, et al.
Publicado: (2016)

Congenital portosystemic venous shunt
por: Papamichail, M., et al.
Publicado: (2017)

Combination therapy using PSE and TIO ameliorates hepatic encephalopathy due to intrahepatic portosystemic venous shunt in idiopathic portal hypertension
por: Kojima, Seiichiro, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_98lltc1a5c8e8ro848etjf0k94